Carley Brian T 4

What Happened
Brian T. Carley, a director of Medpace Holdings, Inc. (MEDP), was granted a derivative award covering 1,110 shares on May 15, 2026. The Form 4 reports the grant as an acquisition of a derivative instrument (1,110 shares at $0.00, reported value $0). This was a grant/award to Carley rather than an open-market buy or sale.

Key Details

• Transaction date: 2026-05-15; filing date (Form 4): 2026-05-18.
• Reported instrument: derivative award covering 1,110 shares (reported price $0.00; total $0 on the Form 4).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: The award is an option that vests on the earlier of (i) the day before the issuer’s first annual meeting after the grant and (ii) the first anniversary of the grant, subject to continued service on the board. (See footnote F1.)
• No indication in the filing that shares were sold immediately or that this was part of a 10b5-1 plan.

Context
This is a typical director compensation grant (a derivative/option award) that vests with continued board service. Such grants do not involve an immediate cash purchase or sale of shares and should be viewed as compensation rather than a direct market signal.